Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib.
Pérez-Lamas L, Díaz AS, Casterá EM, Soto MH, Coll AP, De Las Heras N, Cortes M, Tenza PV, Pacho MS, Magan AS, Angona A, Cervero C, de Paz R, Cuenca AS, Santaliestra M, Marín JL, Casado LF, García-Gutiérrez V.
Pérez-Lamas L, et al. Among authors: pacho ms.
Ann Hematol. 2024 Nov;103(11):4537-4544. doi: 10.1007/s00277-024-05906-6. Epub 2024 Sep 13.
Ann Hematol. 2024.
PMID: 39269475
Free PMC article.